{"status":"OK","data":{"advertisement":{"id":366352,"title":"INC/9/PR153611/ 2026-106897-277298\nzakup i dostawa produktu referencyjnego: Leqvio roztw\u00f3r do wstrzykiwa\u0144; 284 mg/1,5 ml.\nthe purchase and supply of the reference product: Leqvio solution for injection; 284 mg/1.5 ml.","partial_offer_allowed":true,"publication_date":"2026-05-13","submission_deadline":"2026-05-20 23:59:59","planned_sign_date":"2026-05-01","supplementary_orders":"14.7.\tZamawiaj\u0105cy zastrzega sobie prawo do udzielenia Wykonawcy zam\u00f3wie\u0144 dodatkowych, nie obj\u0119tych przedmiotem zam\u00f3wienia podstawowego, je\u015bli zmiany dotycz\u0105 realizacji dodatkowych dostaw, us\u0142ug lub rob\u00f3t budowlanych od dotychczasowego wykonawcy, nieobj\u0119tych zam\u00f3wieniem podstawowym, o ile sta\u0142y si\u0119 niezb\u0119dne i zosta\u0142y spe\u0142nione \u0142\u0105cznie nast\u0119puj\u0105ce warunki:\ni) zmiana wykonawcy nie mo\u017ce zosta\u0107 dokonana z powod\u00f3w ekonomicznych lub technicznych, w szczeg\u00f3lno\u015bci dotycz\u0105cych zamienno\u015bci lub interoperacyjno\u015bci sprz\u0119tu, us\u0142ug lub instalacji, zam\u00f3wionych w ramach zam\u00f3wienia podstawowego,\nii) zmiana wykonawcy spowodowa\u0142aby istotn\u0105 niedogodno\u015b\u0107 lub znaczne zwi\u0119kszenie koszt\u00f3w dla zamawiaj\u0105cego,\niii) warto\u015b\u0107 zmian nie przekracza 50% warto\u015bci zam\u00f3wienia okre\u015blonej pierwotnie w umowie, \n\n14.7.\tThe Contracting Authority reserves the right to award the Contractor additional contracts, not covered by the subject matter of the basic contract, if the changes concern the performance of additional supplies, services or construction works from the existing contractor, not covered by the basic contract, provided that they have become necessary and the following conditions have been met:\ni) the change of contractor cannot be made for economic or technical reasons, in particular those related to the interchangeability or interoperability of equipment, services or installations ordered under the basic contract,\nii) a change of contractor would cause a significant inconvenience or a significant increase in costs for the contracting authority,\niii) the value of the changes does not exceed 50% of the value of the contract originally specified in the contract,","terms_of_contract_change":"13.1.\tZamawiaj\u0105cy zastrzega sobie mo\u017cliwo\u015b\u0107 dokonania istotnych zmian postanowie\u0144 zawartej umowy w stosunku do tre\u015bci oferty, na podstawie kt\u00f3rej dokonano wyboru Wykonawcy, w nast\u0119puj\u0105cym zakresie i sytuacjach:\n13.1.1.\tzmiany przepis\u00f3w prawa Unii Europejskiej lub prawa krajowego w zakresie maj\u0105cym wp\u0142yw na realizacj\u0119 Umowy (w szczeg\u00f3lno\u015bci zmiany stawek podatku VAT);\n13.1.2.\tpoprawienia parametr\u00f3w technicznych przedmiotu zam\u00f3wienia, bez wp\u0142ywu na cen\u0119 rycza\u0142tow\u0105 netto,\n13.1.3.\tprzed\u0142u\u017cenia terminu realizacji zam\u00f3wienia z uwagi na potrzeb\u0119 wykonania prac dodatkowych, kt\u00f3rych wykonanie jest niezb\u0119dne do nale\u017cytego wykonania umowy, a kt\u00f3rych wykonania Zamawiaj\u0105cy, dzia\u0142aj\u0105c z nale\u017cyt\u0105 staranno\u015bci\u0105, nie m\u00f3g\u0142 wcze\u015bniej przewidzie\u0107;\n13.1.4.\tprzed\u0142u\u017cenia terminu realizacji zam\u00f3wienia na skutek dzia\u0142ania si\u0142y wy\u017cszej wraz ze wszystkimi konsekwencjami wyst\u0119puj\u0105cymi w zwi\u0105zku z przed\u0142u\u017ceniem tego terminu;\n13.1.5.\tprzed\u0142u\u017cenia terminu realizacji zam\u00f3wienia z innych przyczyn niezale\u017cnych od Wykonawcy;\n13.1.6.\tzmiany parametr\u00f3w przedmiotu umowy, zmiana zakresu rzeczowego umowy oraz zmiana sposobu wykonania zam\u00f3wienia, nie prowadz\u0105ce do zmiany charakteru umowy \u2013 zmiany technologiczne, w szczeg\u00f3lno\u015bci: konieczno\u015b\u0107 realizacji zam\u00f3wienia przy zastosowaniu innych rozwi\u0105za\u0144 technicznych/technologicznych, materia\u0142owych ni\u017c wskazane w zapytaniu ofertowym, w sytuacji, gdy zastosowanie przewidzianych rozwi\u0105za\u0144 grozi\u0142oby niewykonaniem lub wadliwym wykonaniem umowy;\nWi\u0119cej w za\u0142\u0105cznikach\n\n13.1.\tThe Contracting Authority reserves the right to make significant changes  to the provisions of the concluded contract in relation to the content of the offer on the basis of which the Contractor was selected, in the following scope and situations:\n13.1.1.\tchanges in the provisions of European Union or national law to the extent affecting the performance of the Agreement (in particular changes in VAT rates);\n13.1.2.\timprove the technical parameters of the subject of the contract, without affecting the net lump sum price,\n13.1.3.\textension of the deadline for the performance of the contract due to the need to perform additional works, the performance of which is necessary for the proper performance of the contract, and the performance of which the Ordering Party, acting with due diligence, could not have foreseen in advance;\n13.1.4.\textension of the deadline for the execution of the contract as a result of force majeure along with all the consequences arising in connection with the extension of this deadline;\n13.1.5.\textension of the deadline for the execution of the contract for other reasons beyond the control of the Contractor;\n13.1.6.\tchanges in the parameters of the subject of the contract, change in the material scope of the contract and change in the method of performance of the contract, not leading to a change in the nature of the contract \u2013 technological changes, in particular: the need to perform the contract with the use of technical/technological and material solutions other than those indicated in the request for proposal, in a situation where the application of the envisaged solutions would threaten non-performance or defective performance of the contract;\nMore in attached files","created_at":"2026-05-12 15:09:49","modified_at":"2026-05-21 00:00:29","contact_persons":[{"id":108239,"forename":"Marta","surname":"Patek","phone_number":"","email":"proces.ofertowy@polpharma.com","created_by":null,"created_at":"2026-08-13 08:02:36","modified_at":"2026-08-13 08:02:36","modified_by":null}],"orders":[{"id":592480,"estimated_value":null,"order_items":[{"id":666701,"description":"3.3.\tPrzedmiotem zam\u00f3wienia jest zakup i dostawa produktu referencyjnego Leqvio do wstrzykiwania w ilo\u015bci podanej poni\u017cej, z podzia\u0142em na cz\u0119\u015bci\n3.4.\tPrzedmiot zam\u00f3wienia obejmuje:\nLp.\tSzczeg\u00f3\u0142owy opis przedmiotu zam\u00f3wienia\tIlo\u015b\u0107\nCz\u0119\u015b\u0107 1\tZakup 9 opakowa\u0144 3 r\u00f3\u017cnych serii (po 3 opakowania jednej serii) produktu: Leqvio roztw\u00f3r do wstrzykiwa\u0144; 284 mg/1,5 ml; 1 ampu\u0142kostrzykawka 1,5 ml z rynku US (Stany Zjednoczone Ameryki P\u00f3\u0142nocnej),- 9 opakowa\u0144\nCz\u0119\u015b\u0107 2\tZakup 8 opakowa\u0144 2 r\u00f3\u017cnych serii produktu (po 3 opakowania na jednej serii) oraz zakup 2 opakowa\u0144 trzeciej innej serii produktu: Leqvio roztw\u00f3r do wstrzykiwa\u0144; 284 mg/1,5 ml; 1 ampu\u0142kostrzykawka 1,5 ml z rynku CA (Kanada) - 8 opakowa\u0144\nCz\u0119\u015b\u0107 3\tZakup 8 opakowa\u0144 2 r\u00f3\u017cnych serii produktu (po 3 opakowania jednej serii) oraz zakup 2 opakowa\u0144 trzeciej innej serii produktu: Leqvio roztw\u00f3r do wstrzykiwa\u0144; 284 mg/1,5 ml; 1 ampu\u0142kostrzykawka 1,5 ml z rynku EU (Unia Europejska)- 8 opakowa\u0144\nW ka\u017cdym przypadku, gdy Zamawiaj\u0105cy opisuje przedmiot umowy poprzez wskazanie znak\u00f3w towarowych lub poprzez odniesienie do norm, europejskich ocen technicznych, aprobat, specyfikacji technicznych i/lub system\u00f3w, referencji technicznych, Zamawiaj\u0105cy dopuszcza rozwi\u0105zania r\u00f3wnowa\u017cne z opisanymi. \nR\u00f3wnowa\u017cne rozwi\u0105zania oferowane przez Wykonawc\u0119 b\u0119d\u0105 mia\u0142y co najmniej takie same lub lepsze parametry techniczne i funkcjonalne, co najmniej w zakresie opisanym w ka\u017cdej z norm i nie b\u0119d\u0105 obni\u017ca\u0142y standard\u00f3w ustalonych przez Zamawiaj\u0105cego. \nPrzez poj\u0119cie \u201er\u00f3wnowa\u017cno\u015b\u0107\" rozwi\u0105zania rozumie si\u0119 w szczeg\u00f3lno\u015bci: wykazanie, \u017ce oferowane rozwi\u0105zanie posiada co najmniej takie same lub lepsze - opisane w danej normie - parametry techniczne i cechy jako\u015bci funkcjonalnej, kt\u00f3re odnosz\u0105 si\u0119 do warto\u015bci funkcjonalnych przedmiotu zam\u00f3wienia, w\u0142a\u015bciwych dla materia\u0142u, komponentu, u\u017cytego produktu, takich jak: funkcjonalno\u015b\u0107, wydajno\u015b\u0107, komfort obs\u0142ugi, bezpiecze\u0144stwo, komfort u\u017cytkowania, oraz cechy opisuj\u0105ce cechy fizyczne przedmiotu zam\u00f3wienia. Wykonawca, kt\u00f3ry powo\u0142uje si\u0119 na rozwi\u0105zania r\u00f3wnowa\u017cne, zobowi\u0105zany jest wykaza\u0107, \u017ce oferowane przez niego dostawy spe\u0142niaj\u0105 wymagania okre\u015blone przez Zamawiaj\u0105cego. \nWi\u0119cej informacji w za\u0142\u0105czniku\n\n3.3.\tThe subject of the contract is the purchase and delivery of the reference product Leqvio for injection in the quantity given below, broken down into parts\n3.4.\tThe subject of the order includes:\nLp.\tDetailed description of the subject \tQuantity\nPart 1\tPurchase of 9 packs of 3 different batches (3 packs of one batch) of Leqvio solution for injection; 284 mg/1.5 ml; 1 pre-filled syringe of 1.5 ml from the US (United States of America) market,\n\t9 packs\n\nPart 2\tPurchase of 8 packs of 2 different batches (3 packs per batch) and purchase of 2 packs of the third different batch: Leqvio solution for injection; 284 mg/1.5 ml; 1 pre-filled syringe 1.5 ml from the CA market (Canada) \n\t8 packs\n\nPart 3\tPurchase of 8 packs of 2 different batches (3 packs of one batch) and purchase of 2 packs of a third different batch: Leqvio solution for injection; 284 mg/1.5 ml; 1 pre-filled syringe 1.5 ml from the EU (European Union) market\n\t8 packs\n\nIn each case where the Contracting Authority describes the subject of the contract by indicating trademarks or by referring to standards, European technical assessments, approvals, technical specifications and/or systems, technical references, the Ordering Party allows solutions equivalent to those described. \nEquivalent solutions offered by the Contractor will have at least the same or better technical and functional parameters, at least to the extent described in each of the standards and will not lower the standards set by the Ordering Party.\nThe term \"equivalence\" of a solution is understood in particular: demonstrating that the offered solution has at least the same or better - described in a given standard - technical parameters and functional quality features, which refer to the functional values of the subject of the contract, specific to the material, component, product used, such as: functionality, efficiency, comfort of use, safety, comfort of use, and features describing the physical characteristics of the object order. The Contractor who refers to equivalent solutions is obliged to demonstrate that the supplies offered by it meet the requirements specified by the Ordering Party.\nMore information in attached file","warranty_period":null,"cpv_items":[{"id":3027,"code":"33600000-6","name":"Produkty farmaceutyczne"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"mazowieckie","poviat":"Warszawa","commune":"Ochota","locality":"Warszawa","created_by":null,"created_at":"2026-05-12 15:09:49","modified_at":"2026-05-13 14:23:13","modified_by":null,"id":758676,"type":{"id":1,"name":"adres"},"group_uuid":"ab08c390-900c-4c23-ae13-1c1bf263edc5"}],"participation_conditions":[{"id":1906458,"description":"Zamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek, je\u017celi z\u0142o\u017cy o\u015bwiadczenie, \u017ce dysponuje uprawnieniami niezb\u0119dnymi do prawid\u0142owej realizacji zam\u00f3wienia.\nSpos\u00f3b oceny warunku:\nZamawiaj\u0105cy uzna, \u017ce Wykonawca spe\u0142nia niniejszy warunek, je\u017celi Wykonawca z\u0142o\u017cy \no\u015bwiadczenie o spe\u0142nieniu warunk\u00f3w udzia\u0142u w post\u0119powaniu (Za\u0142\u0105cznik nr 1 do Zapytania \nOfertowego). Zamawiaj\u0105cy zastrzega mo\u017cliwo\u015b\u0107 wezwania Wykonawcy do dostarczenia \ndokument\u00f3w potwierdzaj\u0105cych spe\u0142nienie tego warunku.\n6.1.1.\tthe right to perform a specific activity or activities \nThe Contracting Authority shall consider that the Bidder meets this condition if it submits a declaration that it has the rights necessary for the proper performance of the contract.\nMethod of assessment of the condition:\nThe Contracting Authority shall consider that the Contractor meets this condition if the Contractor submits a statement on the fulfilment of the conditions for participation in the procedure (Appendix No. 1 to the Inquiry \nOffer Agreement). The Contracting Authority reserves the right to call upon the Contractor to deliver documents confirming that this condition is met.","type":{"id":1,"name":"Uprawnienia do wykonywania okre\u015blonej dzia\u0142alno\u015bci lub czynno\u015bci"},"created_by":null,"created_at":"2026-05-13 10:48:03","modified_at":"2026-05-13 14:23:13","modified_by":null,"group_uuid":"8d7655a0-5fe6-4eeb-9ca8-5dcc68ce80b2"},{"id":1906459,"description":"6.1.2.\tsytuacji ekonomicznej lub finansowej\nZamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek, je\u017celi z\u0142o\u017cy o\u015bwiadczenie, \u017ce znajduje si\u0119 w sytuacji ekonomicznej i finansowej zapewniaj\u0105cej prawid\u0142ow\u0105 realizacj\u0119 zam\u00f3wienia, w szczeg\u00f3lno\u015bci nie znajduje si\u0119 w stanie upad\u0142o\u015bci, restrukturyzacji lub likwidacji.\nSpos\u00f3b oceny warunku:\nZamawiaj\u0105cy uzna, \u017ce Wykonawca spe\u0142nia niniejszy warunek, je\u017celi Wykonawca z\u0142o\u017cy \no\u015bwiadczenie o spe\u0142nieniu warunk\u00f3w udzia\u0142u w post\u0119powaniu (Za\u0142\u0105cznik nr 1 do Zapytania \nOfertowego). Zamawiaj\u0105cego zastrzega mo\u017cliwo\u015b\u0107 wezwania Wykonawcy do dostarczenia \ndokument\u00f3w potwierdzaj\u0105cych spe\u0142nienie tego warunku.\n6.1.2.\teconomic or financial situation\nThe Contracting Authority shall consider that the Tenderer meets this condition if it submits a declaration that it is in an economic and financial situation ensuring the proper performance of the contract, in particular it is not in a state of bankruptcy, restructuring or liquidation.\nMethod of assessment of the condition:\nThe Contracting Authority shall consider that the Contractor meets this condition if the Contractor submits a statement on the fulfilment of the conditions for participation in the procedure (Appendix No. 1 to the Inquiry \nOffer Agreement). The Contracting Authority reserves the right to call on the Contractor to provide documents confirming that this condition is met.","type":{"id":5,"name":"Sytuacja ekonomiczna i finansowa"},"created_by":null,"created_at":"2026-05-13 10:48:03","modified_at":"2026-05-13 14:23:13","modified_by":null,"group_uuid":"4a1f4bc9-8ff4-4153-b3a6-68acf0598cbb"},{"id":1906460,"description":"6.2.\tPrzes\u0142anki wykluczenia\n6.2.1.\tZ udzia\u0142u w post\u0119powaniu wykluczone s\u0105 podmioty powi\u0105zane osobowo lub kapita\u0142owo \nz Zamawiaj\u0105cym.\nPrzez powi\u0105zania kapita\u0142owe lub osobowe rozumie si\u0119 wzajemne powi\u0105zania mi\u0119dzy Zamawiaj\u0105cym lub osobami upowa\u017cnionymi do zaci\u0105gania zobowi\u0105za\u0144 w imieniu Zamawiaj\u0105cego, lub osobami wykonuj\u0105cymi w imieniu Zamawiaj\u0105cego czynno\u015bci zwi\u0105zane z przygotowaniem i przeprowadzaniem procedury wyboru wykonawcy a Oferentem, polegaj\u0105ce w szczeg\u00f3lno\u015bci na:\na)\tuczestniczeniu w sp\u00f3\u0142ce jako wsp\u00f3lnik sp\u00f3\u0142ki cywilnej lub sp\u00f3\u0142ki osobowej,\nb)\tposiadaniu co najmniej 10% udzia\u0142\u00f3w lub akcji, o ile ni\u017cszy pr\u00f3g nie wynika z przepis\u00f3w prawa,\nc)\tpe\u0142nieniu funkcji cz\u0142onka organu nadzorczego lub zarz\u0105dzaj\u0105cego, prokurenta, pe\u0142nomocnika,\nd)\tpozostawaniu w zwi\u0105zku ma\u0142\u017ce\u0144skim, w stosunku pokrewie\u0144stwa lub powinowactwa w linii prostej, pokrewie\u0144stwa lub powinowactwa w linii bocznej do drugiego stopnia lub zwi\u0105zaniu z tytu\u0142u przysposobienia, opieki lub kurateli,\ne)\tpozostawaniu we wsp\u00f3lnym po\u017cyciu z Oferentem, jego zast\u0119pc\u0105 prawnym lub cz\u0142onkami organ\u00f3w zarz\u0105dzaj\u0105cych lub organ\u00f3w nadzorczych Oferent\u00f3w ubiegaj\u0105cych si\u0119 o udzielenie zam\u00f3wienia,\nf)\tpozostawaniu z Oferentem w takim stosunku prawnym lub faktycznym, \u017ce istnieje uzasadniona w\u0105tpliwo\u015b\u0107 co do bezstronno\u015bci lub niezale\u017cno\u015bci w zwi\u0105zku z post\u0119powaniem o udzielenie zam\u00f3wienia.\n\nSpos\u00f3b weryfikacji podstaw/braku podstaw wykluczenia:\nWeryfikacja nast\u0105pi na podstawie o\u015bwiadczenia Oferenta oraz o\u015bwiadcze\u0144 Zamawiaj\u0105cego i os\u00f3b wykonuj\u0105cych w imieniu Zamawiaj\u0105cego czynno\u015bci zwi\u0105zanych z przygotowaniem i przeprowadzaniem procedury wyboru wykonawcy.\n\n6.2.2 Z udzia\u0142u w post\u0119powaniu wykluczone s\u0105 r\u00f3wnie\u017c podmioty, w stosunku do kt\u00f3rych zachodz\u0105 okoliczno\u015bci:\na)\tw art. 7 ust. 1 ustawy z dnia 13 kwietnia 2022 r. o szczeg\u00f3lnych rozwi\u0105zaniach w zakresie przeciwdzia\u0142ania wspieraniu agresji na Ukrain\u0119 oraz s\u0142u\u017c\u0105cych ochronie bezpiecze\u0144stwa narodowego (Dz.U. z 2024 r., Poz. 507 t.j. z p\u00f3\u017an. zm.);\nb)\tw art. 5k Rozporz\u0105dzenia Rady (UE) nr 833/2014 z dnia 31 lipca 2014 r. dotycz\u0105cego \u015brodk\u00f3w ograniczaj\u0105cych w zwi\u0105zku z dzia\u0142aniami Rosji destabilizuj\u0105cymi sytuacj\u0119 na Ukrainie (Dz. Urz. UE nr L 229 z 31.07.2014, str. 1), w brzmieniu nadanym Rozporz\u0105dzeniem Rady (UE) nr 2022/576 w sprawie zmiany rozporz\u0105dzenia (UE) nr 833/2014 dotycz\u0105cego \u015brodk\u00f3w ograniczaj\u0105cych w zwi\u0105zku z dzia\u0142aniami Rosji destabilizuj\u0105cymi sytuacj\u0119 na Ukrainie (Dz. Urz. UE nr L 111 z 8.04.2022, str. 1, z p\u00f3\u017an. zm.);\nSpos\u00f3b weryfikacji podstaw/braku podstaw wykluczenia:\nWeryfikacja nast\u0105pi na podstawie o\u015bwiadczenia Oferenta.\n\n6.3.\tOferty z\u0142o\u017cone przez podmioty, kt\u00f3re nie spe\u0142niaj\u0105 warunk\u00f3w udzia\u0142u w post\u0119powaniu b\u0105d\u017a w stosunku do kt\u00f3rych zachodz\u0105 przes\u0142anki do wykluczenia z udzia\u0142u w post\u0119powaniu, podlegaj\u0105 odrzuceniu i nie b\u0119d\u0105 oceniane.\nGROUNDS FOR EXCLUSION FROM THE PROCEEDINGS\n6.2.\tGrounds for exclusion\n6.2.1.\tEntities related to the Ordering Party in terms of personal or capital are excluded from participation in the procedure.\nCapital or personal ties shall be understood as mutual links between the Ordering Party or persons authorised to incur obligations on behalf of the Contracting Authority, or persons performing on behalf of the Contracting Authority activities related to the preparation and conduct of the contractor selection procedure and the Bidder, consisting in particular in:\na)\tparticipation in the company as a partner in a civil partnership or partnership,\nb)\tholding at least 10% of shares or stocks, unless a lower threshold results from the provisions of law,\nc)\tperforming the function of a member of a supervisory or management body, proxy, proxy,\nd)\tbeing married, in a relationship of kinship or affinity in the direct line, kinship or affinity in the collateral line to the second degree, or being connected by adoption, guardianship or guardianship,\ne)\tcohabitation with the Bidder, its legal representative or members of the management or supervisory bodies of the Bidders applying for the award of the contract,\nf)\tremaining in such a legal or factual relationship with the Tenderer that there is a reasonable doubt as to impartiality or independence in connection with the procurement procedure.\n\nMethod of verifying the grounds/absence of grounds for exclusion:\nThe verification will take place on the basis of the Bidder's statement and the statements of the Contracting Authority and persons performing activities related to the preparation and implementation of the contractor selection procedure on behalf of the Contracting Authority.\n\n6.2.2 Entities in relation to which the following circumstances occur are also excluded from participation in the proceedings:\na)\tArticle 7(1) of the Act of 13 April 2022 on special solutions for counteracting support for aggression against Ukraine and for the protection of national security (Journal of Laws of 2024, item 507, as amended);\nb)\tArticle 5k of Council Regulation (EU) No 833/2014 of 31 July 2014 concerning restrictive measures in view of Russia's actions destabilising the situation in Ukraine (Official Journal of the European Union). EU No L 229 of 31.07.2014, p. 1), as amended by Council Regulation (EU) No 2022/576 amending Regulation (EU) No 833/2014 concerning restrictive measures in view of Russia's actions destabilising the situation in Ukraine (OJ L 222, p. OJ L 111 of 8.04.2022, p. 1, as amended. as amended);\nMethod of verifying the grounds/absence of grounds for exclusion:\nThe verification will take place on the basis of the Bidder's statement.\n\n6.3.\tBids submitted by entities that do not meet the conditions for participation in the procedure or for which there are grounds for exclusion from participation in the procedure are subject to rejection and will not be evaluated.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2026-05-13 10:48:03","modified_at":"2026-05-13 14:23:13","modified_by":null,"group_uuid":"b20e9752-c302-4586-b3cb-061438213692"}],"category":{"id":3,"name":"Dostawa"},"subcategory":{"id":15,"name":"Dostawy inne"},"created_by":null,"created_at":"2026-05-12 15:09:49","modified_at":"2026-05-13 14:23:13","modified_by":null,"group_uuid":"52ff3a87-9939-4a45-8805-5f00ff80face"}],"evaluation_criteria":[{"id":1067665,"price_criterion":true,"description":"8.1.\tPrzy ocenianiu ofert Zamawiaj\u0105cy b\u0119dzie kierowa\u0142 si\u0119 podanymi kryteriami: \n-\tCena \u2013 100%, \nWi\u0119cej informacji w za\u0142\u0105cznikach\n8.1.\tWhen evaluating the bids, the Contracting Authority will be guided by the following criteria: \n-\tPrice \u2013 100%, \nMore information in attached file","created_by":null,"created_at":"2026-05-13 10:48:03","modified_at":"2026-05-13 14:23:13","modified_by":null,"group_uuid":"58fb337d-2702-4660-a309-605accaac838"}],"is_variant":false,"title":"Zakup 9 opakowa\u0144  produktu Leqvio z rynku US","order_node":{"id":447526},"created_by":null,"created_at":"2026-05-12 15:09:49","modified_at":"2026-05-13 14:23:13","modified_by":null},{"id":592751,"estimated_value":null,"order_items":[{"id":667126,"description":"3.3.\tPrzedmiotem zam\u00f3wienia jest zakup i dostawa produktu referencyjnego Leqvio do wstrzykiwania w ilo\u015bci podanej poni\u017cej, z podzia\u0142em na cz\u0119\u015bci\n3.4.\tPrzedmiot zam\u00f3wienia obejmuje:\nLp.\tSzczeg\u00f3\u0142owy opis przedmiotu zam\u00f3wienia\tIlo\u015b\u0107\nCz\u0119\u015b\u0107 1\tZakup 9 opakowa\u0144 3 r\u00f3\u017cnych serii (po 3 opakowania jednej serii) produktu: Leqvio roztw\u00f3r do wstrzykiwa\u0144; 284 mg/1,5 ml; 1 ampu\u0142kostrzykawka 1,5 ml z rynku US (Stany Zjednoczone Ameryki P\u00f3\u0142nocnej),- 9 opakowa\u0144\nCz\u0119\u015b\u0107 2\tZakup 8 opakowa\u0144 2 r\u00f3\u017cnych serii produktu (po 3 opakowania na jednej serii) oraz zakup 2 opakowa\u0144 trzeciej innej serii produktu: Leqvio roztw\u00f3r do wstrzykiwa\u0144; 284 mg/1,5 ml; 1 ampu\u0142kostrzykawka 1,5 ml z rynku CA (Kanada) - 8 opakowa\u0144\nCz\u0119\u015b\u0107 3\tZakup 8 opakowa\u0144 2 r\u00f3\u017cnych serii produktu (po 3 opakowania jednej serii) oraz zakup 2 opakowa\u0144 trzeciej innej serii produktu: Leqvio roztw\u00f3r do wstrzykiwa\u0144; 284 mg/1,5 ml; 1 ampu\u0142kostrzykawka 1,5 ml z rynku EU (Unia Europejska)- 8 opakowa\u0144\nW ka\u017cdym przypadku, gdy Zamawiaj\u0105cy opisuje przedmiot umowy poprzez wskazanie znak\u00f3w towarowych lub poprzez odniesienie do norm, europejskich ocen technicznych, aprobat, specyfikacji technicznych i/lub system\u00f3w, referencji technicznych, Zamawiaj\u0105cy dopuszcza rozwi\u0105zania r\u00f3wnowa\u017cne z opisanymi. \nR\u00f3wnowa\u017cne rozwi\u0105zania oferowane przez Wykonawc\u0119 b\u0119d\u0105 mia\u0142y co najmniej takie same lub lepsze parametry techniczne i funkcjonalne, co najmniej w zakresie opisanym w ka\u017cdej z norm i nie b\u0119d\u0105 obni\u017ca\u0142y standard\u00f3w ustalonych przez Zamawiaj\u0105cego. \nPrzez poj\u0119cie \u201er\u00f3wnowa\u017cno\u015b\u0107\" rozwi\u0105zania rozumie si\u0119 w szczeg\u00f3lno\u015bci: wykazanie, \u017ce oferowane rozwi\u0105zanie posiada co najmniej takie same lub lepsze - opisane w danej normie - parametry techniczne i cechy jako\u015bci funkcjonalnej, kt\u00f3re odnosz\u0105 si\u0119 do warto\u015bci funkcjonalnych przedmiotu zam\u00f3wienia, w\u0142a\u015bciwych dla materia\u0142u, komponentu, u\u017cytego produktu, takich jak: funkcjonalno\u015b\u0107, wydajno\u015b\u0107, komfort obs\u0142ugi, bezpiecze\u0144stwo, komfort u\u017cytkowania, oraz cechy opisuj\u0105ce cechy fizyczne przedmiotu zam\u00f3wienia. Wykonawca, kt\u00f3ry powo\u0142uje si\u0119 na rozwi\u0105zania r\u00f3wnowa\u017cne, zobowi\u0105zany jest wykaza\u0107, \u017ce oferowane przez niego dostawy spe\u0142niaj\u0105 wymagania okre\u015blone przez Zamawiaj\u0105cego. \nWi\u0119cej informacji w za\u0142\u0105czniku\n\n3.3.\tThe subject of the contract is the purchase and delivery of the reference product Leqvio for injection in the quantity given below, broken down into parts\n3.4.\tThe subject of the order includes:\nLp.\tDetailed description of the subject \tQuantity\nPart 1\tPurchase of 9 packs of 3 different batches (3 packs of one batch) of Leqvio solution for injection; 284 mg/1.5 ml; 1 pre-filled syringe of 1.5 ml from the US (United States of America) market,\n\t9 packs\n\nPart 2\tPurchase of 8 packs of 2 different batches (3 packs per batch) and purchase of 2 packs of the third different batch: Leqvio solution for injection; 284 mg/1.5 ml; 1 pre-filled syringe 1.5 ml from the CA market (Canada) \n\t8 packs\n\nPart 3\tPurchase of 8 packs of 2 different batches (3 packs of one batch) and purchase of 2 packs of a third different batch: Leqvio solution for injection; 284 mg/1.5 ml; 1 pre-filled syringe 1.5 ml from the EU (European Union) market\n\t8 packs\n\nIn each case where the Contracting Authority describes the subject of the contract by indicating trademarks or by referring to standards, European technical assessments, approvals, technical specifications and/or systems, technical references, the Ordering Party allows solutions equivalent to those described. \nEquivalent solutions offered by the Contractor will have at least the same or better technical and functional parameters, at least to the extent described in each of the standards and will not lower the standards set by the Ordering Party.\nThe term \"equivalence\" of a solution is understood in particular: demonstrating that the offered solution has at least the same or better - described in a given standard - technical parameters and functional quality features, which refer to the functional values of the subject of the contract, specific to the material, component, product used, such as: functionality, efficiency, comfort of use, safety, comfort of use, and features describing the physical characteristics of the object order. The Contractor who refers to equivalent solutions is obliged to demonstrate that the supplies offered by it meet the requirements specified by the Ordering Party.\nMore information in attached file","warranty_period":null,"cpv_items":[{"id":3027,"code":"33600000-6","name":"Produkty farmaceutyczne"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"mazowieckie","poviat":"Warszawa","commune":"Ochota","locality":"Warszawa","created_by":null,"created_at":"2026-05-13 14:12:20","modified_at":"2026-05-13 14:23:13","modified_by":null,"id":759152,"type":{"id":1,"name":"adres"},"group_uuid":"e71d8551-3597-46bb-b324-868f721e6424"}],"participation_conditions":[],"category":{"id":3,"name":"Dostawa"},"subcategory":{"id":15,"name":"Dostawy inne"},"created_by":null,"created_at":"2026-05-13 14:12:20","modified_at":"2026-05-13 14:23:13","modified_by":null,"group_uuid":"bc36f554-77a2-4ebc-b33a-883519901998"}],"evaluation_criteria":[{"id":1067666,"price_criterion":true,"description":"8.1. Przy ocenianiu ofert Zamawiaj\u0105cy b\u0119dzie kierowa\u0142 si\u0119 podanymi kryteriami:\n- Cena \u2013 100%,\nWi\u0119cej informacji w za\u0142\u0105cznikach\n8.1. When evaluating the bids, the Contracting Authority will be guided by the following criteria:\n- Price \u2013 100%,\nMore information in attached file","created_by":null,"created_at":"2026-05-13 10:48:03","modified_at":"2026-05-13 14:23:13","modified_by":null,"group_uuid":"deff6a4d-10fa-4d12-9929-47eb43cce080"}],"is_variant":false,"title":"Zakup 8 opakowa\u0144  produktu  Leqvio z rynku CA","order_node":{"id":447711},"created_by":null,"created_at":"2026-05-13 10:48:03","modified_at":"2026-05-13 14:23:13","modified_by":null},{"id":592752,"estimated_value":null,"order_items":[{"id":667127,"description":"3.3.\tPrzedmiotem zam\u00f3wienia jest zakup i dostawa produktu referencyjnego Leqvio do wstrzykiwania w ilo\u015bci podanej poni\u017cej, z podzia\u0142em na cz\u0119\u015bci\n3.4.\tPrzedmiot zam\u00f3wienia obejmuje:\nLp.\tSzczeg\u00f3\u0142owy opis przedmiotu zam\u00f3wienia\tIlo\u015b\u0107\nCz\u0119\u015b\u0107 1\tZakup 9 opakowa\u0144 3 r\u00f3\u017cnych serii (po 3 opakowania jednej serii) produktu: Leqvio roztw\u00f3r do wstrzykiwa\u0144; 284 mg/1,5 ml; 1 ampu\u0142kostrzykawka 1,5 ml z rynku US (Stany Zjednoczone Ameryki P\u00f3\u0142nocnej),- 9 opakowa\u0144\nCz\u0119\u015b\u0107 2\tZakup 8 opakowa\u0144 2 r\u00f3\u017cnych serii produktu (po 3 opakowania na jednej serii) oraz zakup 2 opakowa\u0144 trzeciej innej serii produktu: Leqvio roztw\u00f3r do wstrzykiwa\u0144; 284 mg/1,5 ml; 1 ampu\u0142kostrzykawka 1,5 ml z rynku CA (Kanada) - 8 opakowa\u0144\nCz\u0119\u015b\u0107 3\tZakup 8 opakowa\u0144 2 r\u00f3\u017cnych serii produktu (po 3 opakowania jednej serii) oraz zakup 2 opakowa\u0144 trzeciej innej serii produktu: Leqvio roztw\u00f3r do wstrzykiwa\u0144; 284 mg/1,5 ml; 1 ampu\u0142kostrzykawka 1,5 ml z rynku EU (Unia Europejska)- 8 opakowa\u0144\nW ka\u017cdym przypadku, gdy Zamawiaj\u0105cy opisuje przedmiot umowy poprzez wskazanie znak\u00f3w towarowych lub poprzez odniesienie do norm, europejskich ocen technicznych, aprobat, specyfikacji technicznych i/lub system\u00f3w, referencji technicznych, Zamawiaj\u0105cy dopuszcza rozwi\u0105zania r\u00f3wnowa\u017cne z opisanymi. \nR\u00f3wnowa\u017cne rozwi\u0105zania oferowane przez Wykonawc\u0119 b\u0119d\u0105 mia\u0142y co najmniej takie same lub lepsze parametry techniczne i funkcjonalne, co najmniej w zakresie opisanym w ka\u017cdej z norm i nie b\u0119d\u0105 obni\u017ca\u0142y standard\u00f3w ustalonych przez Zamawiaj\u0105cego. \nPrzez poj\u0119cie \u201er\u00f3wnowa\u017cno\u015b\u0107\" rozwi\u0105zania rozumie si\u0119 w szczeg\u00f3lno\u015bci: wykazanie, \u017ce oferowane rozwi\u0105zanie posiada co najmniej takie same lub lepsze - opisane w danej normie - parametry techniczne i cechy jako\u015bci funkcjonalnej, kt\u00f3re odnosz\u0105 si\u0119 do warto\u015bci funkcjonalnych przedmiotu zam\u00f3wienia, w\u0142a\u015bciwych dla materia\u0142u, komponentu, u\u017cytego produktu, takich jak: funkcjonalno\u015b\u0107, wydajno\u015b\u0107, komfort obs\u0142ugi, bezpiecze\u0144stwo, komfort u\u017cytkowania, oraz cechy opisuj\u0105ce cechy fizyczne przedmiotu zam\u00f3wienia. Wykonawca, kt\u00f3ry powo\u0142uje si\u0119 na rozwi\u0105zania r\u00f3wnowa\u017cne, zobowi\u0105zany jest wykaza\u0107, \u017ce oferowane przez niego dostawy spe\u0142niaj\u0105 wymagania okre\u015blone przez Zamawiaj\u0105cego. \nWi\u0119cej informacji w za\u0142\u0105czniku\n\n3.3.\tThe subject of the contract is the purchase and delivery of the reference product Leqvio for injection in the quantity given below, broken down into parts\n3.4.\tThe subject of the order includes:\nLp.\tDetailed description of the subject \tQuantity\nPart 1\tPurchase of 9 packs of 3 different batches (3 packs of one batch) of Leqvio solution for injection; 284 mg/1.5 ml; 1 pre-filled syringe of 1.5 ml from the US (United States of America) market,\n\t9 packs\n\nPart 2\tPurchase of 8 packs of 2 different batches (3 packs per batch) and purchase of 2 packs of the third different batch: Leqvio solution for injection; 284 mg/1.5 ml; 1 pre-filled syringe 1.5 ml from the CA market (Canada) \n\t8 packs\n\nPart 3\tPurchase of 8 packs of 2 different batches (3 packs of one batch) and purchase of 2 packs of a third different batch: Leqvio solution for injection; 284 mg/1.5 ml; 1 pre-filled syringe 1.5 ml from the EU (European Union) market\n\t8 packs\n\nIn each case where the Contracting Authority describes the subject of the contract by indicating trademarks or by referring to standards, European technical assessments, approvals, technical specifications and/or systems, technical references, the Ordering Party allows solutions equivalent to those described. \nEquivalent solutions offered by the Contractor will have at least the same or better technical and functional parameters, at least to the extent described in each of the standards and will not lower the standards set by the Ordering Party.\nThe term \"equivalence\" of a solution is understood in particular: demonstrating that the offered solution has at least the same or better - described in a given standard - technical parameters and functional quality features, which refer to the functional values of the subject of the contract, specific to the material, component, product used, such as: functionality, efficiency, comfort of use, safety, comfort of use, and features describing the physical characteristics of the object order. The Contractor who refers to equivalent solutions is obliged to demonstrate that the supplies offered by it meet the requirements specified by the Ordering Party.\nMore information in attached file","warranty_period":null,"cpv_items":[{"id":3027,"code":"33600000-6","name":"Produkty farmaceutyczne"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"mazowieckie","poviat":"Warszawa","commune":"Ochota","locality":"Warszawa","created_by":null,"created_at":"2026-05-13 14:13:15","modified_at":"2026-05-13 14:23:13","modified_by":null,"id":759155,"type":{"id":1,"name":"adres"},"group_uuid":"da0a48d1-7b2b-451e-bed9-f0efb86caa10"}],"participation_conditions":[],"category":{"id":3,"name":"Dostawa"},"subcategory":{"id":15,"name":"Dostawy inne"},"created_by":null,"created_at":"2026-05-13 14:12:20","modified_at":"2026-05-13 14:23:13","modified_by":null,"group_uuid":"f540212e-fe2a-4ab2-805c-0fcb9681f7b3"}],"evaluation_criteria":[{"id":1067667,"price_criterion":true,"description":"8.1. Przy ocenianiu ofert Zamawiaj\u0105cy b\u0119dzie kierowa\u0142 si\u0119 podanymi kryteriami:\n- Cena \u2013 100%,\nWi\u0119cej informacji w za\u0142\u0105cznikach\n8.1. When evaluating the bids, the Contracting Authority will be guided by the following criteria:\n- Price \u2013 100%,\nMore information in attached file","created_by":null,"created_at":"2026-05-13 10:48:03","modified_at":"2026-05-13 14:23:13","modified_by":null,"group_uuid":"942ec45d-0208-40c2-9782-210bc88cce9b"}],"is_variant":false,"title":"Zakup 8 opakowa\u0144  produktu Leqvio z rynku EU","order_node":{"id":447712},"created_by":null,"created_at":"2026-05-13 10:48:03","modified_at":"2026-05-13 14:23:13","modified_by":null}],"created_by":{"id":106897,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Zak\u0142ady Farmaceutyczne Polpharma SA","identification_number_type":"nip","identification_number":"5920202822","address":{"country":"Polska","voivodeship":"pomorskie","poviat":"starogardzki","commune":"Starogard Gda\u0144ski","locality":"Starogard Gda\u0144ski","created_by":null,"created_at":null,"modified_at":null,"modified_by":null,"id":1033525,"street":"Pelpli\u0144ska ","number_description":"19","postcode":"83-200"},"created_by":{"id":106897,"contact_persons":[]},"created_at":"2026-05-12 15:09:49","modified_at":"2026-05-12 15:09:49","modified_by":{"id":106897,"contact_persons":[]},"id":367354},"advertisement":{"id":277298,"number":"2026-106897-277298","publication_date":"2026-05-13","created_by":{"id":106897,"contact_persons":[]},"created_at":"2026-05-12 15:09:49","modified_at":"2026-05-21 00:00:29","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[366352],"enrollment":null,"projects":[{"id":65683,"name":"Opracowanie innowacyjnej platformy technologiczno - analitycznej do produkcji lek\u00f3w zawieraj\u0105cych oligonukleotydy w formie gotowej do u\u017cycia.","number":"0007/25","activity":{"created_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]},"created_at":"2025-08-12 10:03:17","modified_at":"2025-08-12 10:03:17","modified_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]}},"region":null,"institution":{"created_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]},"created_at":"2025-08-12 11:06:27","modified_at":"2025-08-12 11:06:27","modified_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]}},"full_number":"FENG.05.01-IP.01-0007/25","perspective":{},"programme":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"priority":{"created_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]},"created_at":"2025-08-12 10:02:53","modified_at":"2025-08-12 10:02:53","modified_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]}},"type":"project","created_by":{"id":106897,"contact_persons":[]},"created_at":"2025-10-30 08:48:53","modified_at":"2025-10-30 08:48:53","modified_by":{"id":106897,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":366352,"publication_date":"2026-05-13"},"id":2524579,"name":"REQUEST FOR PROPOSAL NO. INC 9.pdf","file":{"id":2802500,"name":"REQUEST FOR PROPOSAL NO. INC 9.pdf","created_at":"2026-05-13 14:22:25","created_by":{"forename":"Marta","surname":"Patek"},"uri":"/api/files/2802500"},"group_uuid":"529344dc-54c0-458f-bc2c-4db490cd22a3"},{"origin":{"id":366352,"publication_date":"2026-05-13"},"id":2524580,"name":"zapytanie ofertowe INC 9.pdf","file":{"id":2802501,"name":"zapytanie ofertowe INC 9.pdf","created_at":"2026-05-13 14:22:41","created_by":{"forename":"Marta","surname":"Patek"},"uri":"/api/files/2802501"},"group_uuid":"badb943b-1be6-4d11-9746-c4f524a9ebfa"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}